(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Research Frontiers Incorporated, SeaChange International, and Rigel Pharmaceuticals.

Rank Financial Asset Price Change Updated (EST)
1 Research Frontiers Incorporated (REFR) 2.81 14.69% 2022-09-20 01:23:14
2 SeaChange International (SEAC) 0.52 8.31% 2022-09-20 07:23:16
3 Rigel Pharmaceuticals (RIGL) 1.32 6.45% 2022-09-20 03:11:07
4 Zai Lab (ZLAB) 49.19 5.78% 2022-09-20 14:58:28
5 American Public Education (APEI) 8.76 5.42% 2022-09-20 14:53:45
6 Rave Restaurant Group (RAVE) 1.20 5.26% 2022-09-19 23:47:14
7 Weibo (WB) 19.00 4.71% 2022-09-20 14:47:42
8 Rubicon Technology (RBCN) 2.91 4.3% 2022-09-19 23:49:16
9 America Movil (AMX) 17.43 4.25% 2022-09-20 14:59:04
10 ProShares UltraPro Short QQQ (SQQQ) 49.92 4.17% 2022-09-20 13:43:13

The three biggest losers today are Spectrum Pharmaceuticals, Ford, and RiceBran Technologies.

Rank Financial Asset Price Change Updated (EST)
1 Spectrum Pharmaceuticals (SPPI) 0.68 -36.18% 2022-09-20 13:15:11
2 Ford (F) 13.12 -12.09% 2022-09-20 14:53:08
3 RiceBran Technologies (RIBT) 1.85 -10.19% 2022-09-20 03:09:08
4 Salisbury Bancorp (SAL) 24.56 -10.05% 2022-09-20 05:09:07
5 FuboTV (FUBO) 4.31 -9.37% 2022-09-20 14:59:21
6 QuantumScape (QS) 10.19 -9.14% 2022-09-20 14:59:47
7 Qumu Corporation (QUMU) 0.65 -9.03% 2022-09-19 23:12:08
8 Quotient Limited (QTNT) 0.19 -8.08% 2022-09-19 23:10:07
9 U.S. Gold Corp (USAU) 4.14 -8% 2022-09-20 14:08:27
10 Redhill Biopharma Ltd. (RDHL) 0.68 -7.52% 2022-09-20 01:10:07

Winners today

1. Research Frontiers Incorporated (REFR) – 14.69%

Research Frontiers Incorporated is a company that develops and sells technology to regulate the flow of light around the world. Companies that produce and market SPD-Smart light-control technology, including light-control films made of the chemical emulsion and light-control panels, can license the suspended particle device (SPD Smart) to them. The electronics used to power the products incorporating the film are also licensed by Research Frontiers Incorporated. The company’s SPD-Smart light control technology can be used in a variety of product applications. These include windows, sunshades and skylights as well as interior partitions for houses and buildings. It serves a variety of applications including architectural, aerospace, marine and appliance. Research Frontiers Incorporated, which was founded in 1965, is located in Woodbury (New York).

NASDAQ ended the session with Research Frontiers Incorporated jumping 14.69% to $2.81 on Tuesday while NASDAQ fell 0.95% to $11,425.05.

Volume

Today’s last reported volume for Research Frontiers Incorporated is 67052 which is 80% above its average volume of 37250.

Research Frontiers Incorporated’s last close was $2.81, 0.35% below its 52-week high of $2.82.

Research Frontiers Incorporated’s Revenue

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 1.22M for the twelve trailing months.

Research Frontiers Incorporated’s Stock Yearly Top and Bottom Value

Research Frontiers Incorporated’s stock is valued at $2.81 at 17:32 EST, below its 52-week high of $2.82 and way above its 52-week low of $1.34.

Research Frontiers Incorporated’s Moving Average

Research Frontiers Incorporated’s value is way higher than its 50-day moving average of $2.03 and way higher than its 200-day moving average of $1.88.

More news about Research Frontiers Incorporated.

2. SeaChange International (SEAC) – 8.31%

SeaChange International, Inc. offers multiscreen, premium over-the top (OTT), video products and services. These products allow for the worldwide aggregation, licensing, management, distribution, and management of advertising and video content. Video products include video back-office which enables content providers to manage the monetization and delivery of a seamless viewing experience across TVs, personal computers (PCs), tablets and smart phones. Media asset management software is also offered by SeaChange International, Inc. This software allows content owners to publish, receive and manage video content that can be viewed on televisions as well as tablets, desktops and PCs. The company also offers an advertising platform that maximizes advertising revenue for multiscreen, broadcast, on demand, and OTT viewing. The company also offers multiscreen client application. This product allows content owners and service providers to maximize live and on-demand video consumption across multiscreens and OTT services. It also offers managed and professional maintenance, technical support, and professional services. It sells its services and products through direct sales, systems integrators, and value-added resellers. The company serves satellite and cable operators as well as broadcasters, content providers, and telecommunications companies. It was founded in 1993 in Boston and has its headquarters in Boston.

NASDAQ ended the session with SeaChange International jumping 8.31% to $0.52 on Tuesday while NASDAQ slid 0.95% to $11,425.05.

Volume

Today’s last reported volume for SeaChange International is 304133 which is 22.49% below its average volume of 392392.

SeaChange International’s last close was $0.52, 84.88% below its 52-week high of $3.44.

SeaChange International’s Revenue

Year-on-year quarterly revenue growth grew by 33.1%, now sitting on 28.98M for the twelve trailing months.

SeaChange International’s Stock Yearly Top and Bottom Value

SeaChange International’s stock is valued at $0.52 at 17:32 EST, way under its 52-week high of $3.44 and way above its 52-week low of $0.38.

SeaChange International’s Moving Average

SeaChange International’s value is below its 50-day moving average of $0.55 and way below its 200-day moving average of $0.96.

More news about SeaChange International.

3. Rigel Pharmaceuticals (RIGL) – 6.45%

Rigel Pharmaceuticals, Inc., is a biotechnology firm that develops small-molecule drugs for rare and severe immune disorders. Tavalisse is an oral spleen Tyrosine Kinase Inhibitor for adult patients suffering from chronic immune thrombocytopenia. Fostamatinib is also being developed by the company. It’s currently in phase 3 clinical trials for warm autoimmune hemolyticanemia, phase 3 clinical trial to treat COVID-19 hospitalized patients and phase 3 clinical trial. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. AstraZeneca AB has a research agreement and license agreement for R256, an oral JAK inhibitor. BerGenBio AS is responsible for developing and commercializing AXL inhibitors. Daiichi Sankyo will develop murine double-minute 2 inhibitors in oncology. Kissei Pharmaceutical Co. Ltd. also has a license and supply arrangement for Fostamatinib. A license agreement and strategic partnership with Eli Lilly and Company allows the company to develop and market R552 in various indications. This includes autoimmune and other inflammatory disorders, and also for non-central nervous systems (non-CNS), disease development candidates. Rigel Pharmaceuticals, Inc., was established in 1996. It is located in South San Francisco, California.

NASDAQ ended the session with Rigel Pharmaceuticals jumping 6.45% to $1.32 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Rigel Pharmaceuticals is 4068900 which is 10.38% below its average volume of 4540350.

Rigel Pharmaceuticals’s last close was $1.32, 66.24% under its 52-week high of $3.91.

Rigel Pharmaceuticals’s Sales

Rigel Pharmaceuticals’s sales growth is a negative 4% for the current quarter and 12.5% for the next.

Rigel Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 43.6%, now sitting on 86.51M for the twelve trailing months.

Rigel Pharmaceuticals’s Stock Yearly Top and Bottom Value

Rigel Pharmaceuticals’s stock is valued at $1.32 at 17:32 EST, way under its 52-week high of $3.91 and way above its 52-week low of $0.64.

Rigel Pharmaceuticals’s Moving Average

Rigel Pharmaceuticals’s value is under its 50-day moving average of $1.39 and way below its 200-day moving average of $2.11.

More news about Rigel Pharmaceuticals.

4. Zai Lab (ZLAB) – 5.78%

Zai Lab Limited is a company that develops and markets therapies for oncology and autoimmune disorders. It also has a focus in neuroscience. Zejula is a once daily small-molecule, poly polymerase 1/2 inhibitor. Optune delivers treatment fields to tumors. NUZYRA treats skin structures and acute bacterial infections. Qinlock can treat gastrointestinal tumors. Odronextamab is also developed to treat diffuse large B cell lymphoma and other types of B-cell lymphoma; Repotrectinib (a tyrosinekinase inhibitor) to target ROS1 or TRK A/B/C patients who have been treated with TKI; Margetuximab to treat breast and stomach cancers; Adagrasib to deal with KRAS G12C-mutated NSCLC and pancreatic cancer; and Bemarituzumab treatment for gastric junction and stomach cancer. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; Tebotelimab, a tetravalent IgG4 monoclonal antibody; Retifanlimab that inhibits interactions between PD-1 and its ligands; ZL-2309, an orally active, selective, and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor; ZL-1201, a humanized IgG4 monoclonal antibody; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; KarXT for the treatment of psychiatric and neurological conditions; ZL-2313, an investigational inhibitor of triple-mutant EGFR harboring; ZL-2314, an investigational inhibitor of double-mutant EGFR harboring; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited, a Shanghai-based company was established in 2013.

NASDAQ ended the session with Zai Lab jumping 5.78% to $49.19 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ fell 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Zai Lab is 259024 which is 54.09% below its average volume of 564317.

Zai Lab’s last close was $46.50, 63.09% under its 52-week high of $125.97.

Zai Lab’s Sales

Zai Lab’s sales growth is 56.6% for the ongoing quarter and 37.7% for the next. The company’s growth estimates for the present quarter and the next is 66.7% and 40.9%, respectively.

Zai Lab’s Revenue

Year-on-year quarterly revenue growth grew by 132.4%, now sitting on 170.93M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zai Lab’s stock is considered to be overbought (>=80).

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $49.19 at 17:32 EST, way below its 52-week high of $125.97 and way higher than its 52-week low of $22.51.

Zai Lab’s Moving Average

Zai Lab’s worth is way above its 50-day moving average of $43.73 and higher than its 200-day moving average of $44.95.

More news about Zai Lab.

5. American Public Education (APEI) – 5.42%

American Public Education, Inc. and its affiliates offer postsecondary education online as well as on-campus. It operates in three distinct segments, American Public University System and Rasmussen University. The company offers 130 degrees and 111 certificates in a variety of fields, such as business administration, law, security and military studies and intelligence. It also offers nursing and health science-focused postsecondary education. This includes a diploma in practical nursing as well as an associate degree of nursing. American Public Education, Inc., was founded in 1991. It is located in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education rising 5.42% to $8.76 on Tuesday while NASDAQ dropped 0.95% to $11,425.05.

Volume

Today’s last reported volume for American Public Education is 241375 which is 28.14% above its average volume of 188363.

American Public Education’s last close was $8.31, 69.15% under its 52-week high of $26.94.

The company’s growth estimates for the ongoing quarter and the next is a negative 2400% and a negative 118%, respectively.

American Public Education’s Revenue

Year-on-year quarterly revenue growth grew by 74.8%, now sitting on 485.01M for the twelve trailing months.

American Public Education’s Stock Yearly Top and Bottom Value

American Public Education’s stock is valued at $8.76 at 17:32 EST, way below its 52-week high of $26.94 and higher than its 52-week low of $8.03.

American Public Education’s Moving Average

American Public Education’s worth is way under its 50-day moving average of $12.88 and way under its 200-day moving average of $17.77.

More news about American Public Education.

6. Rave Restaurant Group (RAVE) – 5.26%

Rave Restaurant Group, Inc., along with its affiliates, operate and franchise pizza delivery/carry out (delco) and express restaurants under Pizza Inn’s trademark in the United States as well as internationally. The company operates in three distinct segments, Pizza Inn Franchising and Pie Five Franchising. Its buffet restaurants can be found in either freestanding buildings or in strip centers within retail developments. They offer delivery and cater services as well as dine in, takeout and catering. The company’s delco restaurant offers delivery and take-out and is located in malls and other retail centers. Express restaurants are available at various points of sale, including convenience stores, grocery shops, colleges campuses, airport terminals and travel plazas. They also serve customers via other non-traditional outlets. It also franchises fast-casual restaurants, under either the Pie Five Pizza Company trademarks or Pie Five. The company owned 33 Pie Five Units franchised, 156 Pizza Inn franchise restaurants and eleven licensed Pizza Inn Express (or PIE) kiosks as of June 27, 2021. In January 2015, the company, formerly Pizza Inn Holdings, Inc., changed its name from Rave Restaurant Group, Inc. Rave Restaurant Group Inc. was established in 1958. It is located in The Colony in Texas.

NASDAQ ended the session with Rave Restaurant Group jumping 5.26% to $1.20 on Tuesday while NASDAQ slid 0.95% to $11,425.05.

Volume

Today’s last reported volume for Rave Restaurant Group is 25734 which is 71.57% below its average volume of 90539.

Rave Restaurant Group’s last close was $1.20, 33.33% under its 52-week high of $1.80.

Rave Restaurant Group’s Revenue

Year-on-year quarterly revenue growth grew by 20%, now sitting on 10.25M for the twelve trailing months.

Rave Restaurant Group’s Stock Yearly Top and Bottom Value

Rave Restaurant Group’s stock is valued at $1.20 at 17:32 EST, way below its 52-week high of $1.80 and way above its 52-week low of $0.82.

Rave Restaurant Group’s Moving Average

Rave Restaurant Group’s value is below its 50-day moving average of $1.30 and above its 200-day moving average of $1.10.

More news about Rave Restaurant Group.

7. Weibo (WB) – 4.71%

Through its subsidiaries, Weibo Corporation operates as a social platform that allows people to share, discover, and create content in China’s People’s Republic of China. The company operates in two main segments: Advertising and Marketing Services and Value-Added Services. It offers discovery products, self-expression products and social products for users who want to share their content. The company also offers advertising and marketing services, including social display ads; promoted marketing offerings such as Fans Headline, Weibo Express and Fans Headline. It also promotes search products and trends that are displayed alongside users’ search behavior and trends discovery. The company also offers products such as trend, search, live streaming and editing tools, content customization and copyright contents pooling and user interaction development. It also provides search list recommendation and trends list recommendation. Weibo opens advertisements. It also provides traffic support and back-end management. The original name of the company was T.CN Corporation. It changed its name in 2012 to Weibo Corporation. It was established in Beijing, China in 2009. Sina Corporation has a subsidiary called Weibo Corporation.

NASDAQ ended the session with Weibo jumping 4.71% to $19.00 on Tuesday while NASDAQ slid 0.95% to $11,425.05.

Volume

Today’s last reported volume for Weibo is 1051390 which is 25.16% above its average volume of 840033.

Weibo’s last close was $18.15, 65.13% under its 52-week high of $52.05.

Weibo’s Sales

Weibo’s sales growth is a negative 22.9% for the present quarter and a decline by 11.7% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 46.8% and a negative 27.8%, respectively.

Weibo’s Revenue

Year-on-year quarterly revenue growth grew by 5.6%, now sitting on 2.28B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Weibo’s stock is considered to be oversold (<=20).

Weibo’s Stock Yearly Top and Bottom Value

Weibo’s stock is valued at $19.00 at 17:32 EST, way under its 52-week high of $52.05 and above its 52-week low of $17.60.

Weibo’s Moving Average

Weibo’s value is under its 50-day moving average of $19.31 and way below its 200-day moving average of $24.81.

More news about Weibo.

8. Rubicon Technology (RBCN) – 4.3%

Rubicon Technology, Inc. supplies monocrystalline sapphire to be used in industrial and optical systems throughout North America and Asia. It offers optical and industrial sapphire products of various sizes and shapes, such as round, rectangular, oval, domes and tubes. These are used in a variety of markets, including defense and aerospace and specialty lighting. The company serves subcontractors in defense, as well as industrial fabricators and resellers. It was founded in 2001 in Bensenville in Illinois.

NASDAQ ended the session with Rubicon Technology jumping 4.3% to $2.91 on Tuesday while NASDAQ fell 0.95% to $11,425.05.

Volume

Today’s last reported volume for Rubicon Technology is 22824 which is 80.97% below its average volume of 119976.

Rubicon Technology’s last close was $2.91, 83.6% under its 52-week high of $17.74.

Rubicon Technology’s Revenue

Year-on-year quarterly revenue growth grew by 96.4%, now sitting on 4.54M for the twelve trailing months.

Rubicon Technology’s Stock Yearly Top and Bottom Value

Rubicon Technology’s stock is valued at $2.91 at 17:32 EST, way below its 52-week high of $17.74 and higher than its 52-week low of $2.78.

Rubicon Technology’s Moving Average

Rubicon Technology’s value is way under its 50-day moving average of $11.99 and way under its 200-day moving average of $9.94.

More news about Rubicon Technology.

9. America Movil (AMX) – 4.25%

America Movil, S.A.B. de C.V. offers telecommunications services throughout Latin America as well as internationally. It offers fixed and wireless voice services as well as network interconnection. These services include local, national, and international long distance services. The company also offers data services such as hosting, data administration and data centers to residential and business clients. It also offers value-added services including Internet access and messaging; data transmission, email, instant messaging and content streaming; wireless security services and machine-to-machine, machine-to–machine, mobile banking and virtual private network service, video calling and personal communication services. The company also offers broadband services for residential customers, IT solutions to large businesses and small corporations and subscriptions to satellite and cable pay TV. It also sells accessories and computers, as well as equipment directories and wireless security. The company offers call center services, software development, advertising and media support, and a telephone directory. The company also provides audio and video content via the Internet, directly from content providers to end users. The company sells products and services under Telcel, Telmex Infinitum and A1 brand names through a network that includes retailers, service centers, corporate clients, as well as through sales representatives. The company has approximately 286.5 millions wireless voice and data customers as of December 31, 2021. America Movil, S.A.B. de C.V. was established in 2000. It is located in Mexico City.

NYSE ended the session with America Movil jumping 4.25% to $17.43 on Tuesday, after three sequential sessions in a row of losses. NYSE dropped 1.36% to $14,474.72, following the last session’s upward trend on what was an all-around negative trend trading session today.

Volume

Today’s last reported volume for America Movil is 3276310 which is 90.88% above its average volume of 1716420.

America Movil’s last close was $16.72, 26.18% under its 52-week high of $22.65.

America Movil’s Sales

America Movil’s sales growth is a negative 15.8% for the current quarter and 0.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 41.7% and 11.8%, respectively.

America Movil’s Revenue

Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 867.47B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

America Movil’s stock is considered to be overbought (>=80).

America Movil’s Stock Yearly Top and Bottom Value

America Movil’s stock is valued at $17.43 at 17:32 EST, way under its 52-week high of $22.65 and higher than its 52-week low of $16.64.

America Movil’s Moving Average

America Movil’s worth is under its 50-day moving average of $18.37 and way below its 200-day moving average of $19.52.

More news about America Movil.

10. ProShares UltraPro Short QQQ (SQQQ) – 4.17%

NASDAQ ended the session with ProShares UltraPro Short QQQ rising 4.17% to $49.92 on Tuesday while NASDAQ fell 0.95% to $11,425.05.

Volume

Today’s last reported volume for ProShares UltraPro Short QQQ is 94689500 which is 20.25% below its average volume of 118746000.

More news about ProShares UltraPro Short QQQ.

Losers Today

1. Spectrum Pharmaceuticals (SPPI) – -36.18%

Spectrum Pharmaceuticals, Inc., is a biopharmaceutical firm that develops and markets oncology-related drug products. ROLONTIS is a long-acting, novel granulocyte-coloy-stimulating protein for chemotherapy-induced neutropenia. Poziotinib is a novel irreversible Tyrosine Kinase Inhibitor for small cell lung cancer tumors. Anti-CD20–IFNa is an antibody-interferon-fusion molecule that targets CD20. It’s currently in Phase I development to treat patients suffering from relapsed, refractory, large-cells. The company has co-developed, commercialized, and in-licensed agreements with Hanmi Pharmaceutical Co. Ltd., as well as a patent-and-technology license agreement with The University of Texas M.D. Anderson Cancer Center and an in-license agreement for ImmunGene, Inc. The company used to be known as NeoTherapeutics, Inc., but changed its name in December 2002 to Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. is located in Henderson, Nevada. It was founded in 1987.

NASDAQ ended the session with Spectrum Pharmaceuticals falling 36.18% to $0.68 on Tuesday while NASDAQ fell 0.95% to $11,425.05.

Volume

Today’s last reported volume for Spectrum Pharmaceuticals is 18495400 which is 359.36% above its average volume of 4026320.

Spectrum Pharmaceuticals’s last close was $1.06, 57.09% below its 52-week high of $2.47.

The company’s growth estimates for the ongoing quarter and the next is 28.6% and 34.6%, respectively.

Spectrum Pharmaceuticals’s Stock Yearly Top and Bottom Value

Spectrum Pharmaceuticals’s stock is valued at $0.68 at 17:32 EST, way below its 52-week high of $2.47 and way higher than its 52-week low of $0.60.

Spectrum Pharmaceuticals’s Moving Average

Spectrum Pharmaceuticals’s worth is way under its 50-day moving average of $1.08 and way below its 200-day moving average of $1.00.

More news about Spectrum Pharmaceuticals.

2. Ford (F) – -12.09%

Ford Motor Company manufactures, markets and supports a wide range of Ford vehicles and trucks. The company operates in three main segments, Automotive, Mobility and Ford Credit. Through distributors and dealers, the Automotive segment sells Ford or Lincoln cars, parts and accessories. Dealers also provide service to commercial fleet customers and daily rental car agencies. Governments can also use dealerships. The Mobility segment provides services for self-driving system development and design. Ford Credit primarily deals in financing and leasing of vehicles to or through dealers. The company offers retail installment sales contracts for used and new cars; direct financing leases of new vehicles for retail or commercial customers such as leasing businesses, government agencies, daily rental firms, fleet customers and other entities. The segment offers wholesale loans for dealers to finance vehicle inventory purchases; loans for dealers to finance working capital, enhance dealer facilities and purchase real estate. ARB Corporation Limited is a strategic partner of the company to create a range of products aftermarket for Ford Bronco. Ford Motor Company was founded in Dearborn in Michigan in 1903.

NYSE ended the session with Ford dropping 12.09% to $13.12 on Tuesday while NYSE fell 1.36% to $14,474.72.

Ford shares are the worst performer in S&P 500 after a $1 billion supply-cost alert
Ford Motor Co.’s stock fell Tuesday to the lowest level since July 27, and it was on track for the largest percentage decline in one day in the past two years. This came after Ford stated that the company expects between 40,000 to 45,000 vehicles unfinished at the end the third quarter. According to recent negotiations, the payments to suppliers will be about $1 billion more than anticipated due to inflation.

Volume

Today’s last reported volume for Ford is 183724000 which is 200.54% above its average volume of 61129800.

Ford’s last close was $14.93, 42.29% below its 52-week high of $25.87.

The company’s growth estimates for the ongoing quarter and the next is 3.9% and 100%, respectively.

Ford’s Revenue

Year-on-year quarterly revenue growth grew by 50.2%, now sitting on 148.03B for the twelve trailing months.

Ford’s Stock Yearly Top and Bottom Value

Ford’s stock is valued at $13.12 at 17:33 EST, way under its 52-week high of $25.87 and way above its 52-week low of $10.61.

Ford’s Moving Average

Ford’s value is under its 50-day moving average of $14.51 and way below its 200-day moving average of $16.20.

More news about Ford.

3. RiceBran Technologies (RIBT) – -10.19%

RiceBran Technologies and its subsidiaries operate as specialty ingredients companies. RiceBran Technologies, together with its subsidiaries, is a specialty ingredient company. It produces, processes, and markets value-added, healthy, natural and nutrient rich products made from rice and small grains. It converts rice bran from raw to stabilized rice bran (SRB), and other high-value derivative products. These include RiBalance which is a nutritional package that includes a healthy carbohydrate, RiSolubles and RiFiber. ProRyza products also contain derivatives made of proteins and blends of protein/fiber. The company’s derivative and SRB products provide nutritional and useful food products. They contain oil, proteins, carbohydrate, vitamins, minerals and fibers to enhance the nutritional quality of consumer products. SRB products from the company are used in animal nutrition markets as feed ingredients. The company serves retailers, wholesalers and food manufacturers in the United States as well as internationally. This company used to be known as NutraCea. In October 2012, RiceBran Technologies was established. RiceBran Technologies was established in 2000. It is located in Tomball Texas.

NASDAQ ended the session with RiceBran Technologies falling 10.19% to $1.85 on Tuesday, after three successive sessions in a row of losses. NASDAQ dropped 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for RiceBran Technologies is 205242 which is 39.27% below its average volume of 337968.

RiceBran Technologies’s last close was $1.85, 79.44% below its 52-week high of $9.00.

RiceBran Technologies’s Sales

RiceBran Technologies’s sales growth is 21.3% for the ongoing quarter and 6.8% for the next.

RiceBran Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 35.7M for the twelve trailing months.

RiceBran Technologies’s Stock Yearly Top and Bottom Value

RiceBran Technologies’s stock is valued at $1.85 at 17:33 EST, way below its 52-week high of $9.00 and above its 52-week low of $1.81.

RiceBran Technologies’s Moving Average

RiceBran Technologies’s worth is way below its 50-day moving average of $2.97 and way below its 200-day moving average of $4.28.

More news about RiceBran Technologies.

4. Salisbury Bancorp (SAL) – -10.05%

Salisbury Bancorp, Inc. is the bank holding firm for Salisbury Bank and Trust Company. It provides retail banking, commercial banking, and trust and wealth advice services. The company offers a variety of commercial and retail deposit products. It also offers loans such as commercial and residential real estate loans, construction loans, working capital loans, equipment loans, and consumer loans. These include home equity loans and lines credit, collateral loans, auto and personal installment loans. It also offers fiduciary services such as trust and estate administration and wealth advisory. Additionally, the company provides investment management services for individuals, families and businesses. The company also offers additional services to depositors, such as landlord/tenant lease secure accounts, services and payroll, ATM services and bank-by-phone, ATM services and bank-by-phone, Internet banking and bill pay services. Person to person payments are possible, as is bank to bank transfer, remote deposit and mobile banking. It also provides cash management and account aggregation, ACH origination and wire transfers. The company operates via a network that includes 14 banks offices and 10 ATMs in Litchfield County (Connecticut); Dutchess Orange and Ulster Counties (New York); and Berkshire County (Massachusetts). It was established in Lakeville in Connecticut in 1848.

NASDAQ ended the session with Salisbury Bancorp sliding 10.05% to $24.56 on Tuesday, following the last session’s downward trend. NASDAQ slid 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Salisbury Bancorp is 21976 which is 251.5% above its average volume of 6252.

Salisbury Bancorp’s last close was $24.56, 18% below its 52-week high of $29.95.

Salisbury Bancorp’s Sales

Salisbury Bancorp’s sales growth is 11.2% for the current quarter and 9.1% for the next. The company’s growth estimates for the current quarter and the next is 28.3% and 8.5%, respectively.

Salisbury Bancorp’s Revenue

Year-on-year quarterly revenue growth declined by 4%, now sitting on 52.16M for the twelve trailing months.

Salisbury Bancorp’s Stock Yearly Top and Bottom Value

Salisbury Bancorp’s stock is valued at $24.56 at 17:33 EST, way below its 52-week high of $29.95 and higher than its 52-week low of $22.50.

Salisbury Bancorp’s Moving Average

Salisbury Bancorp’s worth is higher than its 50-day moving average of $23.68 and under its 200-day moving average of $25.86.

More news about Salisbury Bancorp.

5. FuboTV (FUBO) – -9.37%

FuboTV Inc. provides live streaming for entertainment, sports and news content throughout the United States. Customers can access the fuboTV platform via streaming devices as well as SmartTVs and computers. New York is the headquarters of this company.

NYSE ended the session with FuboTV dropping 9.37% to $4.31 on Tuesday while NYSE fell 1.36% to $14,474.72.

Volume

Today’s last reported volume for FuboTV is 9582080 which is 41.3% below its average volume of 16324700.

FuboTV’s last close was $4.75, 86.47% below its 52-week high of $35.10.

FuboTV’s Sales

FuboTV’s sales growth is 102.2% for the present quarter and 99.7% for the next. The company’s growth estimates for the present quarter is a negative 18.6% and positive 5.9% for the next.

FuboTV’s Revenue

Year-on-year quarterly revenue growth grew by 119.9%, now sitting on 638.35M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FuboTV’s stock is considered to be overbought (>=80).

FuboTV’s Stock Yearly Top and Bottom Value

FuboTV’s stock is valued at $4.31 at 17:33 EST, way below its 52-week high of $35.10 and way higher than its 52-week low of $2.49.

FuboTV’s Moving Average

FuboTV’s worth is way above its 50-day moving average of $3.60 and way under its 200-day moving average of $13.77.

More news about FuboTV.

6. QuantumScape (QS) – -9.14%

QuantumScape Corporation is a company in development. It specializes in the commercialization and development of solid-state lithium metal batteries for electric cars and other uses. It was established in San Jose in California in 2010.

NYSE ended the session with QuantumScape falling 9.14% to $10.19 on Tuesday, after four consecutive sessions in a row of losses. NYSE dropped 1.36% to $14,474.72, following the last session’s upward trend on what was an all-around down trend exchanging session today.

Volume

Today’s last reported volume for QuantumScape is 4448840 which is 24.4% below its average volume of 5885130.

QuantumScape’s last close was $11.21, 73.98% below its 52-week high of $43.08.

The company’s growth estimates for the ongoing quarter and the next is a negative 41.7% and a negative 46.2%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

QuantumScape’s stock is considered to be overbought (>=80).

QuantumScape’s Stock Yearly Top and Bottom Value

QuantumScape’s stock is valued at $10.19 at 17:33 EST, way under its 52-week high of $43.08 and higher than its 52-week low of $10.00.

QuantumScape’s Moving Average

QuantumScape’s value is way below its 50-day moving average of $14.61 and way below its 200-day moving average of $20.48.

More news about QuantumScape.

7. Qumu Corporation (QUMU) – -9.03%

Qumu Corporation offers tools for managing, securing, distributing, measuring, and analyzing live and on-demand video content. The company offers cloud-hosted, perpetual, and term licenses. It also sells hardware accessories and provides support and maintenance. It offers video capture and video content management services. These include creation, editing, video analytics, workflows, security, access control and speech search. The platform also includes extensions and add-ons. The company serves customers in the following areas: banking, finance, insurance, manufacturing services and consulting, telecom, technology and biotech markets. It also supports government clients through channel partners and direct sales. The former name of the company was Rimage Corporation. In September 2013, Qumu Corporation took its current name. Qumu Corporation was established in 1978. It is located in Minneapolis, Minnesota.

NASDAQ ended the session with Qumu Corporation sliding 9.03% to $0.65 on Tuesday while NASDAQ dropped 0.95% to $11,425.05.

Volume

Today’s last reported volume for Qumu Corporation is 30362 which is 21.2% below its average volume of 38534.

Qumu Corporation’s last close was $0.65, 76.95% under its 52-week high of $2.82.

Qumu Corporation’s Sales

Qumu Corporation’s sales growth is a negative 7.5% for the current quarter and a decline by 8.1% for the next. The company’s growth estimates for the current quarter and the next is 19% and 23.8%, respectively.

Qumu Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 12.5%, now sitting on 22.41M for the twelve trailing months.

Qumu Corporation’s Stock Yearly Top and Bottom Value

Qumu Corporation’s stock is valued at $0.65 at 17:33 EST, way below its 52-week high of $2.82 and higher than its 52-week low of $0.60.

Qumu Corporation’s Moving Average

Qumu Corporation’s value is way under its 50-day moving average of $0.74 and way under its 200-day moving average of $1.37.

More news about Qumu Corporation.

8. Quotient Limited (QTNT) – -8.08%

Quotient Limited is a company that develops and manufactures transfusion diagnostic products. It also sells them internationally. MosaiQ is a proprietary platform that provides molecular disease screening and tests for immunohematology. The company’s traditional reagents for blood grouping products include antisera, which are used for the identification blood group antigens. It also offers reagent red cells that enable blood group antibody detection. There are whole blood control products to be used as quality assurance testing and other ancillary products to help support blood grouping. MosaiQ SDS microarray, which is used to screen for cytomegalovirus or Syphilis in serological diseases, is also offered by the company. MosaiQ MDS Microarray is used as a screening test for molecular diseases. MosaiQ H Microarray is used as a microarray for blood grouping; MosaiQ Autoimmune; MosaiQ COVID-19 and MosaiQ iH3 microarray. The company sells products to hospitals and donor collection agencies as well as independent testing labs, original equipment makers, blood banks, and other diagnostics businesses. Quotient Limited was established in 2007, and its headquarters are in Eysins in Switzerland.

NASDAQ ended the session with Quotient Limited falling 8.08% to $0.19 on Tuesday, after two successive sessions in a row of losses. NASDAQ fell 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Quotient Limited is 1914360 which is 51.77% below its average volume of 3969420.

Quotient Limited’s last close was $0.19, 94.04% below its 52-week high of $3.19.

The company’s growth estimates for the present quarter and the next is 14.8% and 65.9%, respectively.

Quotient Limited’s Revenue

Year-on-year quarterly revenue growth declined by 3%, now sitting on 38.24M for the twelve trailing months.

Quotient Limited’s Stock Yearly Top and Bottom Value

Quotient Limited’s stock is valued at $0.19 at 17:33 EST, way under its 52-week high of $3.19 and way higher than its 52-week low of $0.16.

Quotient Limited’s Moving Average

Quotient Limited’s value is way below its 50-day moving average of $0.23 and way below its 200-day moving average of $0.93.

More news about Quotient Limited.

9. U.S. Gold Corp (USAU) – -8%

U.S. Gold Corp. is a precious metals and gold exploration company. The company explores for zinc, copper, silver and gold deposits. It holds an interest in the CK Gold mining project in southeast Wyoming’s Silver Crown. The company also owns interests in Maggie Creek and Keystone exploration properties, which are located on the Cortez Trends and Carlin Trends in Eureka County in Nevada. It also has an interest in Idaho’s Challis-Gold project. Elko is the company’s headquarters. Copper King, LLC was the former parent company of U.S. Gold Corp.

NASDAQ ended the session with U.S. Gold Corp sliding 8% to $4.14 on Tuesday while NASDAQ slid 0.95% to $11,425.05.

Volume

Today’s last reported volume for U.S. Gold Corp is 8050 which is 67.79% below its average volume of 24993.

U.S. Gold Corp’s last close was $4.50, 61.31% below its 52-week high of $11.63.

U.S. Gold Corp’s Stock Yearly Top and Bottom Value

U.S. Gold Corp’s stock is valued at $4.14 at 17:33 EST, way below its 52-week high of $11.63 and way higher than its 52-week low of $3.50.

U.S. Gold Corp’s Moving Average

U.S. Gold Corp’s value is higher than its 50-day moving average of $3.93 and way below its 200-day moving average of $6.00.

More news about U.S. Gold Corp.

10. Redhill Biopharma Ltd. (RDHL) – -7.52%

RedHill Biopharma Ltd. is a biopharmaceutical specialty company that focuses mainly on infectious and gastrointestinal diseases. Movantik, which is used to treat chronic pain in adults suffering from opioid addiction; Talicia for treatment of Helicobacter Pylori infection in adults; Aemcolo to treat travelers’ diarrhea in adult patients. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn’s disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. is an Israeli company that was established in 2009. Its headquarters are in Tel Aviv.

NASDAQ ended the session with Redhill Biopharma Ltd. dropping 7.52% to $0.68 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 0.95% to $11,425.05, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Redhill Biopharma Ltd. is 853140 which is 72.66% below its average volume of 3120670.

Redhill Biopharma Ltd.’s last close was $0.68, 89.62% below its 52-week high of $6.50.

Redhill Biopharma Ltd.’s Sales

Redhill Biopharma Ltd.’s sales growth is a negative 14.1% for the present quarter and 7.3% for the next. The company’s growth estimates for the current quarter and the next is 95% and 94%, respectively.

Redhill Biopharma Ltd.’s Revenue

Year-on-year quarterly revenue growth declined by 11.4%, now sitting on 83.42M for the twelve trailing months.

Redhill Biopharma Ltd.’s Stock Yearly Top and Bottom Value

Redhill Biopharma Ltd.’s stock is valued at $0.68 at 17:33 EST, way under its 52-week high of $6.50 and higher than its 52-week low of $0.62.

Redhill Biopharma Ltd.’s Moving Average

Redhill Biopharma Ltd.’s worth is way under its 50-day moving average of $0.93 and way below its 200-day moving average of $1.70.

More news about Redhill Biopharma Ltd..

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here